药理流行病学的核心概念:药理流行病学的时间到事件分析方法
Gerd Rippin1, Shahrzad Salmasi2, Héctor Sanz3
1Statistical Services, IQVIA Commercial GmbH and Co OHG, Frankfurt, Germany.
Pharmacoepidemiology and drug safety
|October 24, 2024
概括
本综述总结了制药流行病学中的时间到事件 (TTE) 分析方法,包括审查,描述性统计数据和高级回归模型,如Cox比例危险. 它强调了未充分使用的TTE方法,以实现最佳的研究设计.
科学领域:
- 药学流行病学 药学流行病学
- 生物统计学 生物统计学
背景情况:
- 时间到事件 (TTE) 分析在药理流行病学中至关重要,以了解事件随时间的发生.
- 审查是TTE分析的一个关键概念,包括各种类型,如右,左,间隔和信息审查.
研究的目的:
- 提供TTE分析概念和方法的全面概述.
- 为研究人员强调潜在的未充分使用的TTE方法.
- 作为TTE分析在药理学流行病学中的现代摘要.
主要方法:
- 对非参数估计的审查 (卡普兰-梅尔法).
- 参数加速失效时间 (AFT) 模型的解释.
- 讨论半参数的考克斯比例危险和受限平均生存时间 (RMST) 模型.
- 探索TTE模型扩展和TTE结果的因果推理.
主要成果:
- 该审查概述了各种可用和有用的TTE模型.
- 确定了某些TTE概念和方法在研究中的潜在不足利用情况.
结论:
- 本文提供了对TTE分析技术的当代总结.
- 鼓励研究人员为他们的具体研究选择最合适的TTE方法.
- 提供了一个精心策划的参考资料列表,供进一步探索.
相关概念视频
Introduction to Epidemiology
655
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
655
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Introduction To Survival Analysis
184
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
184
Study Designs in Epidemiology
185
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
185
Kaplan-Meier Approach
102
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
102


